['We are pleased to announce great news for Pfiz....er I mean the Shareholders with this recent FDA approval.
However, with Pfizer's impending takeover which we highly recommend because of all these key risks we are incapable of managing, you still should really really accept whatever Pfizer offer as a significant premium to the historic low share price we trashed. Please be aware that the more new tech we get FDA approved and patented, the more cost and risk there is if you trust us with your money!']
Announcement from the BOD probably.
It is always interesting to see the BOD tie themselves in knots trying to spin good news in such a way that the insulting takeover offer at the bottom of the range of the independent expert doesn't need to be increased. It just reeks of incompetency in negotiations.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-40
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online